EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Real-World Use of Upadacitinib for Moderate-to-Severe Atopic Dermatitis in Saudi Arabia: A Single-Centre Retrospective Descriptive Analysis

Hamad Almutlaq

Clinical, Cosmetic and Investigational Dermatology · 2026-08 · Volume 19 · 1-15

DOI: 10.2147/ccid.s628527 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical, Cosmetic and Investigational Dermatology, 2026-08. Verfasst von Hamad Almutlaq. Beteiligte Einrichtung: Department of Dermatology, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Janus kinase inhibitorsUpadacitinibatopicdermatitis

Autor:innen und Institutionen

  • Department of Dermatology, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.

Zitieren

APA

Almutlaq, H. (2026). Real-World Use of Upadacitinib for Moderate-to-Severe Atopic Dermatitis in Saudi Arabia: A Single-Centre Retrospective Descriptive Analysis. Clinical, Cosmetic and Investigational Dermatology, Volume 19, 1-15. https://doi.org/10.2147/ccid.s628527

Vancouver

Almutlaq H. Real-World Use of Upadacitinib for Moderate-to-Severe Atopic Dermatitis in Saudi Arabia: A Single-Centre Retrospective Descriptive Analysis. Clinical, Cosmetic and Investigational Dermatology. 2026;Volume 19:1-15. doi:10.2147/ccid.s628527

BibTeX
@article{Almutlaq2026,
  author = {Almutlaq, Hamad},
  title = {Real-World Use of Upadacitinib for Moderate-to-Severe Atopic Dermatitis in Saudi Arabia: A Single-Centre Retrospective Descriptive Analysis},
  journal = {Clinical, Cosmetic and Investigational Dermatology},
  year = {2026},
  volume = {Volume 19},
  pages = {1--15},
  doi = {10.2147/ccid.s628527}
}
Kostenlos starten →